nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C8—Ifosfamide—testicular cancer	0.135	0.185	CbGbCtD
Gemfibrozil—CYP2C19—Ifosfamide—testicular cancer	0.114	0.155	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—testicular cancer	0.101	0.138	CbGbCtD
Gemfibrozil—CYP2C9—Ifosfamide—testicular cancer	0.0945	0.129	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—testicular cancer	0.0647	0.0882	CbGbCtD
Gemfibrozil—CYP3A4—Ifosfamide—testicular cancer	0.0549	0.0749	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—testicular cancer	0.0501	0.0683	CbGbCtD
Gemfibrozil—CYP2C9—Cisplatin—testicular cancer	0.046	0.0626	CbGbCtD
Gemfibrozil—CYP3A4—Vinblastine—testicular cancer	0.0291	0.0397	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—testicular cancer	0.0263	0.0358	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—testicular cancer	0.0179	0.0244	CbGbCtD
Gemfibrozil—Oedema—Cisplatin—testicular cancer	0.000573	0.00215	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Cisplatin—testicular cancer	0.000573	0.00215	CcSEcCtD
Gemfibrozil—Pain—Ifosfamide—testicular cancer	0.000568	0.00213	CcSEcCtD
Gemfibrozil—Constipation—Ifosfamide—testicular cancer	0.000568	0.00213	CcSEcCtD
Gemfibrozil—Loss of consciousness—Etoposide—testicular cancer	0.000565	0.00212	CcSEcCtD
Gemfibrozil—Nervous system disorder—Cisplatin—testicular cancer	0.000562	0.00211	CcSEcCtD
Gemfibrozil—Cough—Etoposide—testicular cancer	0.000561	0.00211	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Cisplatin—testicular cancer	0.000561	0.0021	CcSEcCtD
Gemfibrozil—Asthenia—Bleomycin—testicular cancer	0.000558	0.00209	CcSEcCtD
Gemfibrozil—Convulsion—Etoposide—testicular cancer	0.000557	0.00209	CcSEcCtD
Gemfibrozil—Skin disorder—Cisplatin—testicular cancer	0.000556	0.00209	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—testicular cancer	0.000552	0.00207	CcSEcCtD
Gemfibrozil—Pruritus—Bleomycin—testicular cancer	0.00055	0.00206	CcSEcCtD
Gemfibrozil—Feeling abnormal—Ifosfamide—testicular cancer	0.000547	0.00205	CcSEcCtD
Gemfibrozil—Chest pain—Etoposide—testicular cancer	0.000547	0.00205	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—testicular cancer	0.000547	0.00205	CcSEcCtD
Gemfibrozil—Nausea—Vinblastine—testicular cancer	0.000547	0.00205	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—testicular cancer	0.000546	0.00205	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000543	0.00204	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000543	0.00204	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—testicular cancer	0.000542	0.00203	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—testicular cancer	0.000541	0.00203	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—testicular cancer	0.000535	0.00201	CcSEcCtD
Gemfibrozil—Confusional state—Etoposide—testicular cancer	0.000529	0.00199	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—testicular cancer	0.000528	0.00198	CcSEcCtD
Gemfibrozil—Urticaria—Ifosfamide—testicular cancer	0.000528	0.00198	CcSEcCtD
Gemfibrozil—Abdominal pain—Ifosfamide—testicular cancer	0.000525	0.00197	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—testicular cancer	0.000525	0.00197	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Etoposide—testicular cancer	0.000525	0.00197	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000522	0.00196	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—testicular cancer	0.00052	0.00195	CcSEcCtD
Gemfibrozil—Paraesthesia—Cisplatin—testicular cancer	0.000514	0.00193	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Etoposide—testicular cancer	0.000514	0.00193	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—testicular cancer	0.000512	0.00192	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—testicular cancer	0.000511	0.00192	CcSEcCtD
Gemfibrozil—Skin disorder—Etoposide—testicular cancer	0.00051	0.00191	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—testicular cancer	0.000509	0.00191	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—testicular cancer	0.000507	0.0019	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—testicular cancer	0.000506	0.0019	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—testicular cancer	0.000504	0.00189	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—testicular cancer	0.0005	0.00188	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—testicular cancer	0.000496	0.00186	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—testicular cancer	0.000495	0.00186	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000494	0.00186	CcSEcCtD
Gemfibrozil—Vomiting—Bleomycin—testicular cancer	0.000494	0.00185	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—testicular cancer	0.000491	0.00184	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—testicular cancer	0.000491	0.00184	CcSEcCtD
Gemfibrozil—Rash—Bleomycin—testicular cancer	0.00049	0.00184	CcSEcCtD
Gemfibrozil—Pain—Cisplatin—testicular cancer	0.00049	0.00184	CcSEcCtD
Gemfibrozil—Dermatitis—Bleomycin—testicular cancer	0.00049	0.00184	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—testicular cancer	0.000488	0.00183	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—testicular cancer	0.000484	0.00182	CcSEcCtD
Gemfibrozil—Asthenia—Ifosfamide—testicular cancer	0.000477	0.00179	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—testicular cancer	0.000474	0.00178	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—testicular cancer	0.000472	0.00177	CcSEcCtD
Gemfibrozil—Feeling abnormal—Cisplatin—testicular cancer	0.000472	0.00177	CcSEcCtD
Gemfibrozil—Paraesthesia—Etoposide—testicular cancer	0.000471	0.00177	CcSEcCtD
Gemfibrozil—Pruritus—Ifosfamide—testicular cancer	0.00047	0.00176	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—testicular cancer	0.000469	0.00176	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—testicular cancer	0.000468	0.00176	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—testicular cancer	0.000466	0.00175	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—testicular cancer	0.000466	0.00175	CcSEcCtD
Gemfibrozil—Nausea—Bleomycin—testicular cancer	0.000462	0.00173	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—testicular cancer	0.000461	0.00173	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—testicular cancer	0.000457	0.00172	CcSEcCtD
Gemfibrozil—Diarrhoea—Ifosfamide—testicular cancer	0.000454	0.00171	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—testicular cancer	0.000454	0.00171	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—testicular cancer	0.000453	0.0017	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Etoposide—testicular cancer	0.000453	0.0017	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—testicular cancer	0.000452	0.0017	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—testicular cancer	0.000452	0.0017	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—testicular cancer	0.000449	0.00169	CcSEcCtD
Gemfibrozil—Pain—Etoposide—testicular cancer	0.000449	0.00168	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—testicular cancer	0.000449	0.00168	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—testicular cancer	0.000448	0.00168	CcSEcCtD
Gemfibrozil—Dizziness—Ifosfamide—testicular cancer	0.000439	0.00165	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000437	0.00164	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—testicular cancer	0.000436	0.00164	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—testicular cancer	0.000433	0.00162	CcSEcCtD
Gemfibrozil—Feeling abnormal—Etoposide—testicular cancer	0.000432	0.00162	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—testicular cancer	0.00043	0.00162	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—testicular cancer	0.000429	0.00161	CcSEcCtD
Gemfibrozil—Vomiting—Ifosfamide—testicular cancer	0.000422	0.00159	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—testicular cancer	0.000419	0.00157	CcSEcCtD
Gemfibrozil—Rash—Ifosfamide—testicular cancer	0.000419	0.00157	CcSEcCtD
Gemfibrozil—Dermatitis—Ifosfamide—testicular cancer	0.000418	0.00157	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000418	0.00157	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—testicular cancer	0.000417	0.00156	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—testicular cancer	0.000416	0.00156	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—testicular cancer	0.000415	0.00156	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—testicular cancer	0.000415	0.00156	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—testicular cancer	0.000415	0.00156	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—testicular cancer	0.000413	0.00155	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—testicular cancer	0.000412	0.00155	CcSEcCtD
Gemfibrozil—Asthenia—Cisplatin—testicular cancer	0.000411	0.00154	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—testicular cancer	0.000407	0.00153	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000403	0.00151	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—testicular cancer	0.000399	0.0015	CcSEcCtD
Gemfibrozil—Nausea—Ifosfamide—testicular cancer	0.000394	0.00148	CcSEcCtD
Gemfibrozil—Diarrhoea—Cisplatin—testicular cancer	0.000392	0.00147	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—testicular cancer	0.000391	0.00147	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—testicular cancer	0.000387	0.00145	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—testicular cancer	0.000387	0.00145	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—testicular cancer	0.000384	0.00144	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—testicular cancer	0.000381	0.00143	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—testicular cancer	0.000377	0.00142	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—testicular cancer	0.000376	0.00141	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—testicular cancer	0.000376	0.00141	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—testicular cancer	0.000373	0.0014	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—testicular cancer	0.000371	0.00139	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—testicular cancer	0.000366	0.00137	CcSEcCtD
Gemfibrozil—Vomiting—Cisplatin—testicular cancer	0.000364	0.00137	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—testicular cancer	0.000363	0.00136	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—testicular cancer	0.000363	0.00136	CcSEcCtD
Gemfibrozil—Rash—Cisplatin—testicular cancer	0.000361	0.00136	CcSEcCtD
Gemfibrozil—Dermatitis—Cisplatin—testicular cancer	0.000361	0.00135	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—testicular cancer	0.000359	0.00135	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—testicular cancer	0.000358	0.00134	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—testicular cancer	0.000356	0.00134	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—testicular cancer	0.000355	0.00133	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—testicular cancer	0.000354	0.00133	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—testicular cancer	0.000353	0.00132	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—testicular cancer	0.00035	0.00131	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—testicular cancer	0.000347	0.0013	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—testicular cancer	0.000346	0.0013	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—testicular cancer	0.000345	0.0013	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—testicular cancer	0.000345	0.00129	CcSEcCtD
Gemfibrozil—Nausea—Cisplatin—testicular cancer	0.00034	0.00128	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—testicular cancer	0.00034	0.00127	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—testicular cancer	0.000338	0.00127	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—testicular cancer	0.000336	0.00126	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—testicular cancer	0.000335	0.00126	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—testicular cancer	0.000334	0.00125	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—testicular cancer	0.000334	0.00125	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—testicular cancer	0.000333	0.00125	CcSEcCtD
Gemfibrozil—Rash—Etoposide—testicular cancer	0.000331	0.00124	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—testicular cancer	0.00033	0.00124	CcSEcCtD
Gemfibrozil—Headache—Etoposide—testicular cancer	0.000329	0.00123	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—testicular cancer	0.000328	0.00123	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—testicular cancer	0.000328	0.00123	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—testicular cancer	0.000328	0.00123	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—testicular cancer	0.000328	0.00123	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—testicular cancer	0.000327	0.00123	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—testicular cancer	0.000326	0.00123	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000325	0.00122	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—testicular cancer	0.000324	0.00122	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—testicular cancer	0.000324	0.00122	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—testicular cancer	0.000323	0.00121	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—testicular cancer	0.000322	0.00121	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—testicular cancer	0.000317	0.00119	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—testicular cancer	0.000317	0.00119	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—testicular cancer	0.000314	0.00118	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—testicular cancer	0.000314	0.00118	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—testicular cancer	0.000314	0.00118	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—testicular cancer	0.000312	0.00117	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—testicular cancer	0.000312	0.00117	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—testicular cancer	0.000308	0.00116	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—testicular cancer	0.000308	0.00116	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—testicular cancer	0.000308	0.00115	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—testicular cancer	0.000307	0.00115	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—testicular cancer	0.000307	0.00115	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—testicular cancer	0.000307	0.00115	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—testicular cancer	0.000305	0.00115	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000305	0.00114	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—testicular cancer	0.0003	0.00112	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—testicular cancer	0.000299	0.00112	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—testicular cancer	0.000298	0.00112	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—testicular cancer	0.000296	0.00111	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—testicular cancer	0.000294	0.0011	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—testicular cancer	0.000294	0.0011	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—testicular cancer	0.000293	0.0011	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—testicular cancer	0.000291	0.00109	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—testicular cancer	0.000289	0.00109	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—testicular cancer	0.000289	0.00108	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—testicular cancer	0.000288	0.00108	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—testicular cancer	0.000288	0.00108	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000286	0.00107	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—testicular cancer	0.000286	0.00107	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—testicular cancer	0.000284	0.00107	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—testicular cancer	0.000284	0.00107	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—testicular cancer	0.000284	0.00107	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—testicular cancer	0.000282	0.00106	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000282	0.00106	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—testicular cancer	0.000279	0.00105	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—testicular cancer	0.000277	0.00104	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—testicular cancer	0.000274	0.00103	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—testicular cancer	0.000272	0.00102	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—testicular cancer	0.000272	0.00102	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000271	0.00102	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—testicular cancer	0.000271	0.00102	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—testicular cancer	0.000269	0.00101	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000268	0.00101	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—testicular cancer	0.000268	0.001	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—testicular cancer	0.000267	0.001	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—testicular cancer	0.000266	0.001	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—testicular cancer	0.000264	0.000992	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—testicular cancer	0.000264	0.000991	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—testicular cancer	0.000261	0.000981	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—testicular cancer	0.000259	0.000972	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—testicular cancer	0.000259	0.000972	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—testicular cancer	0.000257	0.000964	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000254	0.000953	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—testicular cancer	0.000254	0.000952	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—testicular cancer	0.000251	0.000944	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—testicular cancer	0.000251	0.000944	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—testicular cancer	0.00025	0.000937	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—testicular cancer	0.000248	0.000932	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000248	0.00093	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—testicular cancer	0.000244	0.000917	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—testicular cancer	0.000242	0.00091	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—testicular cancer	0.000242	0.000908	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—testicular cancer	0.00024	0.000903	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—testicular cancer	0.000239	0.000899	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000235	0.000882	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—testicular cancer	0.000235	0.00088	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—testicular cancer	0.000234	0.000877	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—testicular cancer	0.000233	0.000873	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—testicular cancer	0.000233	0.000873	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—testicular cancer	0.000232	0.000873	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—testicular cancer	0.000225	0.000846	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—testicular cancer	0.000224	0.000842	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000222	0.000835	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—testicular cancer	0.000222	0.000834	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—testicular cancer	0.000216	0.000811	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—testicular cancer	0.000215	0.000807	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—testicular cancer	0.000215	0.000807	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—testicular cancer	0.000211	0.000792	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—testicular cancer	0.000208	0.000781	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—testicular cancer	0.000208	0.00078	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—testicular cancer	0.000201	0.000755	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—testicular cancer	0.0002	0.00075	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—testicular cancer	0.000198	0.000744	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—testicular cancer	0.000198	0.000743	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—testicular cancer	0.000197	0.000739	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—testicular cancer	0.000195	0.000733	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—testicular cancer	0.000194	0.00073	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—testicular cancer	0.000192	0.000723	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—testicular cancer	0.000187	0.000702	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—testicular cancer	0.000187	0.000701	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—testicular cancer	0.000186	0.000699	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—testicular cancer	0.000185	0.000696	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—testicular cancer	0.000185	0.000695	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—testicular cancer	0.000184	0.000691	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—testicular cancer	0.00018	0.000675	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—testicular cancer	0.000175	0.000656	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—testicular cancer	0.000173	0.000649	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—testicular cancer	0.000172	0.000644	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—testicular cancer	0.000171	0.000643	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—testicular cancer	0.00017	0.00064	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—testicular cancer	0.000162	0.000607	CcSEcCtD
